miltefosine
- RxCUI
- 1494066
- RxNorm name
- miltefosine
- Term type
- IN
- Status
- Active
- Updated
- 2026-10-06 01:49:39
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 052014
- Active start
- 052014
- Multiple ingredient
- NO
- Branded
- NO
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | miltefosine | 1 | NAMES |
| RxNorm Name | miltefosine | 1 | NAMES |
| TTY | IN | 1 | ATTRIBUTES |
| SPL_SET_ID | bcb387ac-2e90-4f5e-94b2-d3635190678e | 1 | CODES |
| UNII_CODE | 53EY29W7EC | 1 | CODES |
| RxCUI | 1494066 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IMPAVIDO | MILTEFOSINE | Profounda, Inc. | bcb387ac-2e90-4f5e-94b2-d3635190678e | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | MILTEFOSINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | P01CX | Other agents against leishmaniasis and trypanosomiasis | ATC1-4 | miltefosine | |
| FDASPL | N0000190851 | Antileishmanial | EPC | has_epc | miltefosine |
| MEDRT | D010767 | Phosphorylcholine | CHEM | has_ingredient | miltefosine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | miltefosine |
| MEDRT | D016773 | Leishmaniasis, Cutaneous | DISEASE | may_treat | miltefosine |
| MEDRT | D007898 | Leishmaniasis, Visceral | DISEASE | may_treat | miltefosine |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | miltefosine |
| MEDRT | D016111 | Sjogren-Larsson Syndrome | DISEASE | ci_with | miltefosine |
| MEDRT | N0000181812 | Lysophospholipid Receptor Interactions | MOA | has_moa | miltefosine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | ATC | P01CX04 |
| CODES | DRUGBANK | DB09031 |
| CODES | SNOMEDCT | 713642004 |
| CODES | SNOMEDCT | 713676008 |
| CODES | USP | m9338 |
| CODES | VUID | 4035630 |
| SOURCES | Source | Anatomical Therapeutic Chemical |
| SOURCES | Source | Drug Bank |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |